Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (341-350 of 415) with videos related to

Pageof 42
Sort By:
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trialMarc Blondon, Sara Cereghetti, Jérôme Pugin, et al.
AIDS (London, England)|September 29, 2022
Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trialsFrancois Venter, Simiso Sokhela, Alexandra Calmy, et al.
Plos Pathogens|August 13, 2025
Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1Marius Zeeb, Katharina Kusejko, Sonja Hartnack, et al.
The Lancet. HIV|October 3, 2020
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in CameroonAlexandra Calmy, Tamara Tovar Sanchez, Charles Kouanfack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2022
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk GroupHuyen Nguyen, Benjamin Hampel, David Garcia Nuñez, et al.
BMC Infectious Diseases|April 17, 2025
Mycoplasma genitalium infection in Eswatini amid syndromic case management: prevalence, coinfections, diagnostic challenges and treatment gapsBernhard Kerschberger, Skinner Lekelem, Michelle Daka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2020
Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIVTanja Engel, Marieke Raffenberg, Isabella C Schoepf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2025
Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical DataLena Bartl, Marius Zeeb, Marisa Kälin, et al.
The Journal of Infectious Diseases|April 16, 2024
Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir TherapyLorin Begré, Anders Boyd, Marie-Laure Plissonnier, et al.
HGG Advances|June 18, 2026
Genome-wide association study of untargeted plasma metabolomic profiles identifies host genetic regulation in people with HIVMariam Ait Oumelloul, Adriaan van der Graaf, Simon Tang, et al.
Pageof 42

Showing results (341-350 of 415) with videos related to

Sort By:
Pageof 42
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trialMarc Blondon, Sara Cereghetti, Jérôme Pugin, et al.
AIDS (London, England)|September 29, 2022
Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trialsFrancois Venter, Simiso Sokhela, Alexandra Calmy, et al.
Plos Pathogens|August 13, 2025
Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1Marius Zeeb, Katharina Kusejko, Sonja Hartnack, et al.
The Lancet. HIV|October 3, 2020
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in CameroonAlexandra Calmy, Tamara Tovar Sanchez, Charles Kouanfack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2022
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk GroupHuyen Nguyen, Benjamin Hampel, David Garcia Nuñez, et al.
BMC Infectious Diseases|April 17, 2025
Mycoplasma genitalium infection in Eswatini amid syndromic case management: prevalence, coinfections, diagnostic challenges and treatment gapsBernhard Kerschberger, Skinner Lekelem, Michelle Daka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2020
Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIVTanja Engel, Marieke Raffenberg, Isabella C Schoepf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2025
Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical DataLena Bartl, Marius Zeeb, Marisa Kälin, et al.
The Journal of Infectious Diseases|April 16, 2024
Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir TherapyLorin Begré, Anders Boyd, Marie-Laure Plissonnier, et al.
HGG Advances|June 18, 2026
Genome-wide association study of untargeted plasma metabolomic profiles identifies host genetic regulation in people with HIVMariam Ait Oumelloul, Adriaan van der Graaf, Simon Tang, et al.
Pageof 42